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Abstract
Problem/Condition: In 1996, CDC initiated data collection regarding assisted reproductive technology (ART) proce-
dures performed in the United States to determine medical center-specific pregnancy success rates, as mandated by the
Fertility Clinic Success Rate and Certification Act (FCSRCA) (Public Law 102-493, October 24, 1992). ART includes
fertility treatments in which both eggs and sperm are handled in the laboratory (i.e., in vitro fertilization and related
procedures). Patients who undergo ART treatments are more likely to deliver multiple-birth infants than women who
conceive naturally. Multiple births are associated with increased risk for mothers and infants (e.g., pregnancy complica-
tions, premature delivery, low-birthweight infants, and long-term disability among infants).
Reporting Period Covered: 2000.
Description of System: CDC contracts with a professional society, the Society for Assisted Reproductive Technology
(SART), to obtain data from fertility medical centers located in the United States. Since 1997, CDC has compiled data
related to ART procedures. The Assisted Reproductive Technology Surveillance System was initiated by CDC in col-
laboration with the American Society for Reproductive Medicine, the Society for Assisted Reproductive Technology,
and RESOLVE: The National Infertility Association.
Results: In 2000, a total of 25,228 live-birth deliveries and 35,025 infants resulting from 99,629 ART procedures were
reported to CDC from 383 medical centers that performed ART in the United States and U.S. territories. Nationally,
75,516 (76%) of ART treatments were freshly fertilized embryos using the patient’s eggs; 13,312 (13%) were thawed
embryos using the patient’s eggs; 7,919 (8%) were freshly fertilized embryos from donor eggs; and 2,882 (3%) were
thawed embryos from donor eggs. The national live-birth delivery per transfer rate was 30.8%. The five states that
reported the highest number of ART procedures were California (13,194), New York (11,239), Massachusetts (8,041),
Illinois (7,323), and New Jersey (5,506). These five states also reported the highest number of live-birth deliveries and
infants born as a result of ART. Overall, 47% of women undergoing ART-transfer procedures using freshly fertilized
embryos from their own eggs were aged <35 years; 23% were aged 35–37 years; 19% were aged 38–40 years; 7% were
aged 41–42 years; and 4% were aged >42 years. Among ART treatments in which freshly fertilized embryos from the
patient’s eggs were used, substantial variation in patient age, infertility diagnoses, history of past infertility treatment,
and past births was observed. Nationally, live-birth rates were highest for women aged <35 years (38%). The risk for a
multiple-birth delivery was highest for women who underwent ART-transfer procedures using freshly fertilized em-
bryos from either donor eggs (40%) or from their own eggs (35%). Among women who underwent ART-transfer
procedures using freshly fertilized embryos from their own eggs, further variation by patient age and number of em-
bryos transferred was observed. Of the 35,025 infants born, 44% were twins, and 9% were triplet and higher order
multiples, for a total multiple-infant birth rate of 53%. Patient’s residing in states with the highest number of live-birth
deliveries also reported the highest number of infants born in multiple-birth deliveries.
Interpretation: Whether an ART procedure was successful (defined as resulting in a pregnancy and live-birth delivery)
varied according to different patient and treatment factors. Patient factors included the age of the woman undergoing
ART, whether she had previously given birth, whether she had previously undergone ART, and the infertility diagnosis
of both the female and male partners. Treatment factors included whether eggs were from the patient or a woman
serving as an egg donor, whether the embryos were freshly fertilized or previously frozen and thawed, how long the
embryos were kept in culture, how many embryos were transferred, and whether various specialized treatment proce-
dures were used in conjunction with ART. ART poses a major risk for multiple births. This risk varied according to the
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Introduction
For >2 decades, assisted reproductive technologies (ARTs)
have been used by couples to overcome infertility. ARTs in-
clude those infertility treatments in which both eggs and sperm
are handled in the laboratory (i.e., in vitro fertilization and
related procedures). Since the birth of the first U.S. infant
conceived with ART in 1981, use of these treatments has in-
creased dramatically. Each year, both the number of medical
centers providing ART services and the total number of pro-
cedures performed have increased notably (1).
In 1992, Congress passed the Fertility Clinic Success Rate
and Certification Act (FCSRCA),* which requires each medi-
cal center in the United States that performs ART to report
data to CDC annually and to include every ART procedure
initiated. CDC uses the data to report medical center-specific
pregnancy success rates. In 1997, CDC published the first
surveillance report under this mandate (2). That report was
based on ART procedures performed in 1995. Since then,
CDC has continued to publish a surveillance report annually
that details each medical center’s success rates. CDC has also
used this surveillance data file to perform more in-depth analy-
ses of infant outcomes (e.g., multiple births) (3,4). Multiple-
infant births are associated with greater health problems for
both mothers and infants, including higher rates of caesarean
deliveries, prematurity, low birthweight, and infant death and
disability. This report is based on ART surveillance data pro-
vided to CDC’s National Center for Chronic Disease Preven-
tion and Health Promotion (NCCDPHP), Division of
Reproductive Health, regarding procedures performed in
2000. A report of these data according to the medical center
in which the procedure was performed was published sepa-
rately (1). In this report, emphasis is on presenting state-spe-
cific data and presenting more detailed data regarding
multiple-birth risk for 2000.
Methods
Each year, the Society for Assisted Reproductive Technol-
ogy (SART), an organization of ART providers affiliated with
the American Society for Reproductive Medicine, collects data
regarding ART procedures from medical centers performing
ART in the United States and its territories and provides these
data to CDC by contract. Data collected include patient de-
mographics, medical history and infertility diagnoses, clinical
information pertaining to the ART procedure, and informa-
tion regarding resultant pregnancies and births. The data file
is organized with one record per ART procedure performed.
Multiple procedures from a single patient are not linked. De-
spite the federal mandate, certain centers (6%–7%/year) have
not reported their data; the majority of these are believed to
be smaller than average practices. For this report, data per-
taining to ART procedures initiated January 1–December 31,
2000, are presented.
ART data and outcomes from ART are presented by state
of residence. In cases of missing residency data (10%), the
state of residency was assigned as the state in which the ART
procedure was performed. Additionally, data regarding num-
ber of procedures are presented by treatment type and stage of
treatment. ART procedures are usually classified into four
groups according to whether a woman used her own eggs or
received eggs from a donor and whether or not the embryos
transferred were freshly fertilized or previously frozen and
thawed. Because both success rates and multiple-birth risk
vary substantially among these four treatments groups, data
are presented separately for each type.
In addition to treatment types, within a given treatment
procedure, different stages exist. A typical ART procedure
begins when a woman starts taking drugs to stimulate egg
production or begins having her ovaries monitored with the
intent of having embryos transferred. If eggs are produced,
the procedure progresses to the egg retrieval stage. After the
eggs are retrieved, they are combined with sperm in the labo-
ratory, and if fertilization is successful, the resulting embryos
are selected for transfer. If the embryo implants in the uterus,
the cycle progresses to a clinical pregnancy (i.e., the presence
* Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA),
Public Law 102-493, October 24, 1992.
patient’s age, the type of ART procedure performed, and the number of embryos transferred. In addition, the increased
risk for multiple births has a notable population impact in certain states.
Public Health Actions: As use of ART and ART success rates continue to increase, ART-related multiple births are an
increasingly important public health problem nationally and in many states. The proportion of infants born through
ART in 2000 that were multiple births (53%) was substantially higher than in the general U.S. population during the
same period. Data in this report indicate a need to reduce multiple births associated with ART. Efforts should be made
to limit the number of embryos transferred for patients undergoing ART. In addition, continued research and surveil-
lance is key to understanding the effect of ART on maternal and child health.
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of a gestational sac detectable by ultrasound). The resulting
pregnancy might progress to a live-birth delivery. A live-birth
delivery is defined as the delivery of >1 live-born infant. Only
ART procedures involving freshly fertilized eggs include an
egg retrieval stage; ART procedures using thawed eggs do not
include egg retrieval because eggs were fertilized during a pre-
vious procedure and the resulting embryos were frozen until
the current procedure. An ART procedure can be discontin-
ued at any step for medical reasons or by the patient’s choice.
Variations in a typical ART procedure are noteworthy. Al-
though a typical ART procedure includes in vitro fertilization
(IVF) of gametes, culture for >2 days and embryo transfer
into the uterus (i.e., transcervical embryo transfer), in certain
cases, unfertilized gametes (eggs and sperm) or zygotes (early
embryos [i.e., a cell that results from fertilization of the egg by
a sperm]) are transferred into the fallopian tubes within a day
or two of retrieval. These are known as gamete and zygote
intrafallopian transfer (GIFT and ZIFT). Another adaptation
is intracytoplasmic sperm injection (ICSI) in which fertiliza-
tion is still in vitro but is accomplished by selection of a single
sperm that is injected directly into the egg. This technique
was originally developed for couples with male factor infertil-
ity but is now commonly used for an array of diagnostic groups.
Detailed data are presented in this report for the most com-
mon treatment type, those using freshly fertilized embryos
from the patient’s eggs. These procedures account for >70%
of the total number of ART procedures performed each year.
For those procedures that progressed to the embryo-transfer
stage, percentage distribution of selected patient and treat-
ment factors were calculated. In addition, success rates, de-
fined as live-birth deliveries per ART-transfer procedure, were
calculated according to the same patient and treatment char-
acteristics.
Patient factors included the age of the woman undergoing
ART, whether she had previously given birth, the number of
past ART attempts, and the infertility diagnosis of both the
female and male partners. The patient’s age at the time of the
ART procedure were grouped into five categories: aged <35
years, 35–37 years, 38–40 years, 41–42 years, and >42 years.
Diagnoses ranged from one factor in one partner to multiple
factors in one or both partners and were categorized as
• tubal factor — the woman’s fallopian tubes are blocked
or damaged, causing difficulty for the egg to be fertilized
or for an embryo to travel to the uterus;
• ovulatory dysfunction — the ovaries are not producing
eggs normally; such dysfunctions include polycystic ova-
rian syndrome and multiple ovarian cysts;
• diminished ovarian reserve — the ability of the ovary to
produce eggs is reduced; reasons include congenital, medi-
cal, or surgical causes or advanced age (>40 years);
• endometriosis — involves the presence of tissue similar
to the uterine lining in abnormal locations; this condi-
tion can affect both fertilization of the egg and embryo
implantation;
• uterine factor — a structural or functional disorder of the
uterus that results in reduced fertility;
• male factor — a low sperm count or problems with sperm
function that cause difficulty for a sperm to fertilize an
egg under normal conditions;
• other causes of infertility — immunological problems or
chromosomal abnormalities, cancer chemotherapy, or se-
rious illnesses;
• unexplained cause — no cause of infertility was detected
in either partner;
• multiple factors, female — diagnosis of >1 female cause;
or
• multiple factors, male and female — diagnosis of >1 fe-
male cause and male factor infertility.
Treatment factors included
• the number of days the embryo was cultured;
• the number of embryos that were transferred;
• whether the procedure was IVF-transfer only, IVF with
ICSI, GIFT, ZIFT, or a combination of IVF with or with-
out ICSI and either GIFT or ZIFT; and
• whether a woman other than the patient (a surrogate)
gestated the pregnancy (i.e., a gestational carrier).
The number of embryos transferred in an ART procedure
was categorized as 1, 2, 3, 4, or >5. The number of days of
embryo culture was calculated by using dates of egg retrieval
and embryo transfer and was categorized as 1–6. However,
because of limited sample sizes, live-birth rates are presented
only for the two most common days, 3 and 5. Likewise, live-
birth rates are presented for IVF with and without ICSI only
and not for GIFT and ZIFT.
Multiple birth was assessed in two ways. First, each multiple-
birth delivery was defined as a single event. A multiple-birth
delivery was defined as the delivery of >2 infants in which at
least one was live-born. The multiple-birth risk was thus cal-
culated as the proportion of multiple-birth deliveries among
total live-birth deliveries. Multiple birth was also assessed ac-
cording to the proportion of infants from multiple deliveries
among total infants (i.e., each infant was considered separately
in this calculation). The proportion of live-born infants who
were multiples (twins and triplets or more) was then calcu-
lated. Each of these measures represents a different focus. The
multiple-birth risk, based on number of deliveries (or infant
sets), provides an estimate of the individual risk posed by ART
to the woman for multiple birth. The proportion of infants
born in a multiple-birth delivery provides a measure of the
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effect of ART treatments on children in the population. Both
measures are presented by type of ART treatment and by
maternal age for births conceived with the patient’s eggs.
Multiple-birth risk is further presented by number of embryos
transferred. Proportion of infants born in a multiple-birth
delivery is presented separately by state of residency. All analyses
were performed by using SAS software system (5).
Results
A total of 99,629 ART procedures performed in 2000 were
reported to CDC (Table 1). The largest number of ART pro-
cedures occurred among patients who used their own freshly
fertilized embryos (75,516; 76%). Of the 99,629 procedures
started, 81,915 (82%) progressed to embryo transfer. Over-
all, 37% of ART procedures that progressed to the transfer
stage resulted in a pregnancy, and 31% resulted in a live-birth
delivery. Both pregnancy and live-birth rates varied according
to type of ART. The highest rates were observed among ART
procedures using donor eggs and freshly fertilized embryos
(51% pregnancy rate and 44% live-birth rate). The lowest
rates were observed among procedures using the patient’s eggs
and thawed embryos (26% pregnancy rate and 20% live-birth
rate).
In all, the 25,228 live-birth deliveries from ART procedures
resulted in 35,025 infants (Table 1); the number of infants
born was higher than the number of live-birth deliveries be-
cause of multiple-infant births. The largest proportion of in-
fants born (76.5%; n = 26,800) were from ART procedures
in which patients used freshly fertilized embryos from their
own eggs.
Of 408 medical centers in the United States and surround-
ing territories that performed ART in 2000, a total of 383
provided data to CDC (Figure 1). The majority of medical
centers that provided ART services were located in the eastern
United States, in or near major cities. Within states, the num-
ber of medical centers performing ART was variable. Four
states had no ART medical centers (Alaska, Maine, Montana,
and Wyoming). States with the largest number of ART cen-
ters were California (56), Florida (28), New York (28), Illi-
nois (25), and Texas (24).
The number of ART procedures performed among residents
of each state approximately paralleled the data by medical cen-
ter location (Table 2). The greatest numbers of ART proce-
dures reported in 2000 were performed among residents of
California (13,194), New York (11,239), Massachusetts
(8,041), Illinois (7,323), and New Jersey (5,506). The five
states with the largest number of ART procedures performed
also reported the majority of live-birth deliveries and infants
born. ART was used by residents of certain states and territo-
ries without an ART medical center (e.g., Alaska, Guam,
Maine, Montana, Northern Mariana Islands, Virgin Islands,
and Wyoming); however, each accounted for a limited per-
centage of total ART usage in the United States. Non-U.S.
residents accounted for an estimated 1% of ART procedures,
live-birth deliveries, and infants born.
Forty-seven percent of ART-transfer procedures using freshly
fertilized embryos from the patient’s eggs were performed on
women aged <35 years; 23% on women aged 35–37 years;
19% on women aged 38–40 years; 7% on women aged 41–
42; and 4% on women aged >42 years. Patient and treatment
characteristics of these women varied by age (Table 3). The
most common diagnoses reported for infertility among couples
were male factor and tubal factor; however, diagnoses varied
overall. Tubal factor, male factor, endometriosis, and ovula-
tory dysfunction were more commonly reported among
younger women than women in older age categories. In con-
trast, diminished ovarian reserve was reported for only 1% of
women aged <35 years; it was reported for 12% of women
aged 41–42 years, and 22% of women aged >42 years. Among
all women, 10%–12% were reported as having unexplained
infertility; 11%–16% were reported as having multiple fe-
male factors; and 17%–18% were reported as having both
male and female factors.
Approximately 60% of women aged <35 years were under-
going their first ART procedure. The percentage of women
who had undergone at least one previous ART procedure in-
creased with increasing age: only 40% of women aged >42
years were undergoing their first ART procedure. The per-
centage of women who had had a previous birth followed simi-
lar patterns. Although 19% of women aged <35 years reported
at least one previous birth, this increased steadily with age:
>35% of women in the oldest age group had had a previous
birth.†
The majority of ART procedures used IVF with or without
ICSI. Only a limited proportion of ART procedures used
GIFT or ZIFT. Use of ICSI demonstrated a slight inverse
relationship with patient age; these findings are consistent with
higher rates of male factor infertility among younger age
groups. In all age groups, the majority of procedures included
embryo culture for 3 days; the next most common procedure
involved embryo culture to day 5. Culture to day 5 coincides
with development of the embryo to the blastocyst stage, which
was used more frequently among younger women.
Although limited variation existed by age, the majority of
ART procedures involved transfer of >1 embryo. Among
women aged <35 years, 96% of procedures involved transfer
† Data were not available to distinguish whether previous births were
conceived naturally or conceived with ART or other infertility treatments.
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of >2 embryos, and 63% involved transfer of >3 embryos. For
women aged >42 years, 86% involved transfer of >2 embryos,
and 68% involved transfer of >3 embryos. Use of a gesta-
tional carrier or surrogate was <1% for all age groups.
Live-birth rates for women who underwent ART procedures
using freshly fertilized embryos from their own eggs also var-
ied by patient age and selected patient and treatment factors
(Table 4). Although the average live-birth rate for ART-
transfer procedures performed among women who used their
own freshly fertilized eggs was 32%, live-birth rates ranged
from 38% among women aged <35 years to 6% among women
aged >42 years (Table 4). Women aged <40 years who had an
infertility diagnosis of ovulatory dysfunction or endometrio-
sis or had unexplained infertility tended to have higher live-
birth rates. Women aged >40 years with a diagnosis of uterine
factor had above average live-birth rates (22% for women aged
41–42 years and 15% for women aged >42 years). Across all
age groups, a diagnosis of diminished ovarian reserve was re-
lated to lower live-birth rates. Also, live-birth rates were lower
for couples with a diagnosis of multiple factors, particularly
male and female factors. Women aged <42 years who had
undergone a previous ART procedure had lower live-birth rates
than women undergoing their first ART procedure. However,
the number of previous ART procedures cannot be subdi-
vided by whether they were successful or not. Women aged
<42 years who had had >1 previous birth had higher live-
birth rates than those with no previous births. Women aged
>42 years had low live-birth rates overall (6%), regardless of
whether they had had a previous ART or a previous birth.
ART procedures in which IVF was used with ICSI had lower
live-birth rates in all age groups (Table 4). Live-birth rates
were higher for women who had had extended embryo cul-
ture to day 5 than for women who had embryos cultured to
day 3; this pattern was also observed for all age groups. In
addition, among all age groups, the highest live-birth rates
were observed among women who had transferred >2 em-
bryos and among women who had used a gestation carrier.
However, all of the results for treatment factors need to be
considered cautiously because treatment was not randomized
but rather based on medical center assessment and patient
choice.
Of 8,806 multiple-birth deliveries, 6,784 were from preg-
nancies conceived with freshly fertilized embryos from the
patient’s eggs; 609 were from thawed embryos from the
patient’s eggs; 1,236 were from freshly fertilized embryos from
a donor’s eggs; and 177 were from thawed embryos from a
donor’s eggs (Table 5). In comparison with ART procedures
using the patient’s eggs and freshly fertilized embryos, the risks
for multiple-birth delivery were increased when eggs from a
donor were used and decreased when thawed embryos were
used. Among ART procedures in which the patient’s own eggs
were used, a strong inverse relation existed between multiple-
birth risk and patient age. The average multiple-birth risk (i.e.,
multiple-birth delivery rate) for ART procedure in which
freshly fertilized embryos from the patient’s eggs were used
was 35%. This rate varied from 39% among women aged
<35 years to 12% among women aged >42 years.
Of 35,025 infants born through ART, 53% (18,603) were
born in multiple-birth deliveries (Table 5). The proportion of
infants born in a multiple-birth delivery also varied by type of
ART procedure and patient age.
A more detailed examination of multiple-birth risk for
women who underwent ART procedures in which freshly fer-
tilized embryos from their own eggs were used revealed that
number of embryos transferred was a risk factor for multiple-
birth delivery, but the magnitude of the risk varied according
to patient age (Figures 2–6). Among all age groups, transfer
of >2 embryos resulted in increased live-birth delivery rates.
However, the multiple-birth risk was also substantially in-
creased. Among women aged <35 years (Figure 2) and 35–37
years (Figure 3), the percentage of twin deliveries increased
steadily with increasing number of embryos transferred from
two to five or more. The percentage of triplet and higher or-
der multiple-birth deliveries demonstrated an even more
marked increase as the number of embryos transferred in-
creased. As a result, the percentage of singleton deliveries for
both of these two youngest age groups was actually lower when
>3 embryos were transferred in comparison with two embryos
being transferred. For women aged 38–40 years (Figure 4),
transfer of >3 embryos offered a certain advantage in terms of
live-birth delivery rates. However, as among younger age
groups, the percentage of twin deliveries and triplet or higher
order multiple-birth deliveries were substantially increased with
>3 embryos having been transferred compared with two. For
women aged 41–42 years (Figure 5), both the live-birth deliv-
ery rate and the multiple-birth risk increased steadily with an
increased number of embryos having been transferred. The
percentage of triplet or higher order multiple-birth deliveries
did not demonstrate a trend. For women aged >42 years (Fig-
ure 6), the percentage of twin deliveries (11%–13%) and triplet
or higher order multiple-birth deliveries (0%–2%) did not
vary substantially by number of embryos (>2) having been
transferred.§
The total number and percentage of infants born in mul-
tiple-birth deliveries by maternal state of residency is presented
§ Results are based on total multiple-birth risk and thus do not provide an
indication of pregnancies that began as twins, triplets, or more, but reduced
(either spontaneously or through medical intervention) to singletons or
twins (see Figures 2–6).
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(Table 6). Among states and territories with one or more total
infants, conceived through ART, the numbers of infants born
in multiple-birth deliveries ranged from 0 for residents of the
Virgin Islands to 2,315 for California residents. The states
with the highest number of ART-associated live-birth deliver-
ies also had the highest number of infants born in multiple-
birth deliveries. These include California (2,315), New York
(1,946), Massachusetts (1,268), New Jersey (1,205), and Illi-
nois (1,099). Nationally, the percentage of infants born in
multiple-birth deliveries after ART was used was 53%; the
percentage of twins and triplets or more were 44% and 9%,
respectively. The percentage of infants born in multiple-birth
deliveries was >50% in the majority of states. The states with
the highest proportion of infants born in multiple-birth de-
liveries were Wyoming (69%), Nevada (62%), North Caro-
lina (61%), Idaho (61%), and Oregon (60%).
Discussion
According to the latest estimates of infertility in the United
States from the 1995 National Survey of Family Growth, 15%
of women of reproductive age reported a past infertility-
associated health-care visit, and 2% reported a visit in the past
year (6). Among married couples in which the woman was of
reproductive age, 7% reported they had not conceived after
12 months of unprotected intercourse. With advances in ART,
couples are increasingly turning to these treatments to over-
come their infertility.
Since the birth of the first infant through ART in the United
States in 1981, use of ART has grown substantially. Since 1997,
CDC has been monitoring ART procedures performed in the
United States. During that time, a notable and consistent in-
crease in the use of ART has occurred. The increased use of
ART coupled with increases in ART success rates has resulted
in dramatic increases in the number of children conceived
through ART each year. From 1996 (i.e., the first full year for
which CDC collected data) through 2000, the number of ART
procedures performed increased 54%, from 64,724 to 99,629
(1). Additionally, live-birth rates for all types of ART proce-
dures increased from 11% to 22% during 1996–2000. The
number of infants conceived through ART increased 67%,
from 20,921 infants conceived through ART procedures per-
formed in 1996 to 35,025 infants conceived through ART
procedures performed in 2000.
This report documents that in 2000, ART use varied ac-
cording to state of residency. Residents of California, New
York, Massachusetts, Illinois, and New Jersey reported the
highest number of ART procedures. These states also reported
the highest number of infants conceived through ART. In
2000, ART use by state of residency was partly in line with
expectations based on the total population size of women of
reproductive age (i.e., women aged 15–44 years) within states
(7). For example, California, New York, and Illinois were in
the top five states for both ART usage and total number of
women of reproductive age. However, ART use did not com-
pletely parallel population size. Whereas Massachusetts had
the third highest number of ART procedures performed, it
ranked thirteenth in terms of women of reproductive age. Like-
wise, New Jersey ranked fifth according to ART use, but ranked
tenth according to population size. This divergence is not com-
pletely surprising because both Massachusetts and New Jersey
had statewide mandates for insurance coverage for ART pro-
cedures in 2000. The state variation might also be related to
availability of ART services within each state. However, we
cannot disentangle the relation between demand for services
and availability (i.e., increased availability in certain states
might reflect the increased demand for ART among state
residents).
Patients with an array of characteristics used ART services.
Among ART treatments in which freshly fertilized embryos
from the patient’s eggs were used (i.e., the most frequent type
of ART treatment), substantial variation was observed in pa-
tient age, infertility diagnoses, history of past infertility treat-
ment, and past births.
Success rates from ART use are affected by numerous pa-
tient and treatment factors; hence, considering one single
measure of success in evaluating ART efficacy is not informa-
tive. At a minimum, ART treatments need to be subdivided
into general categories on the basis of the source of the egg
(patient or donor) and the status of the embryos (freshly fer-
tilized or thawed) because success rates vary substantially across
these types. Within the type of ART treatment, further varia-
tion exists in success rates by patient and treatment factors,
most notably patient age. Other factors to consider when as-
sessing success rates are infertility diagnosis, number of previ-
ous ART procedures, number of previous births, type of ART
procedure, number of days of embryo culture, number of em-
bryos transferred, and use of a gestational carrier (surrogate).
Variation exists in success rates according to each of these
factors.
CDC’s primary focus in collecting ART data has been live-
birth deliveries as an indicator of success, because ART sur-
veillance activities were developed in response to a federal
mandate to report ART success rate data. Thus, a key role for
CDC has been to publish standardized data related to ART
success rates, including information regarding factors that af-
fect these rates. With these data, couples can make informed
decisions regarding whether to undergo this time-consuming
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and expensive treatment (8,9).¶ However, success-rate data
must also be balanced with consideration of effects on mater-
nal and infant health. Thus, CDC also closely monitors mul-
tiple births conceived through ART.
Multiple births are associated with an increased health risk
for both mothers and infants (10–12). Women with multiple-
gestation pregnancies are at increased risk for maternal com-
plications (e.g., hemorrhage and hypertension). Infants born
in a multiple-birth delivery are at increased risk for prematu-
rity, low birthweight, infant mortality, and long-term disabil-
ity. The health risks associated with multiple births have also
contributed to rising health-care costs. In 2000, the estimated
costs (per family) of delivering multiple-gestation pregnan-
cies resulting from ART procedures ranged from $58,865 for
twins to $281,698 for quadruplets (12). Additionally, a study
regarding costs per delivery resulting from IVF pregnancies
estimated $39,000 for singleton or twin pregnancies and
$340,000 for triplet and quadruplet pregnancies (13).
In the United States, multiple births have increased dra-
matically during the last 2 decades (14,15). The rise in mul-
tiple births has been attributed to an increased use of ART
and delayed childbearing (4,16,17). A recent study concern-
ing trends in multiple births reported that 14% of multiple
births in the United States in 2000 were attributed to ART;
the proportions of twins and triplets or more attributed to
ART were 12% and 43%, respectively (4). Other non-ART
infertility treatments were estimated to also have contributed
substantially to multiple births in the United States. Thus,
even with shifts toward delayed child-bearing and the con-
comitant increase in multiple births known to be associated
with advanced maternal age, by 2000, only 67% of twin births
and 18% of triplet or higher order multiple births were esti-
mated to have been naturally conceived.
In this report, 53% of infants born through ART in 2000
were multiple births; this compares with 3% in the general
U.S. population during the same period (14,18). The twin
rate was 44%, 22 times higher than in the general U.S. popu-
lation (2%); the triplet and higher order multiples rate was
9%, 50 times higher than the general U.S. population (0.18%).
Regarding the specific type of ART treatment, the rates are
even higher for women who underwent ART procedures us-
ing freshly fertilized embryos from their own eggs (54% total
multiple births) or from donor eggs (59% total multiple
births). In the majority of states, >50% of infants conceived
through ART were born in multiple-birth deliveries. North
Carolina, Nevada, Idaho, Oregon, and Wyoming reported
ART-associated multiple-birth rates >60%. Multiple births re-
sulting from ART are an increasing public health problem,
nationally and for the majority of states. The findings in this
report confirm the need to reduce the occurrence of multiple
births resulting from ART.
This analysis was subject to certain limitations. First, ART
surveillance data are reported for each ART procedure per-
formed rather than for each patient who used ART. Linking
procedures among patients who underwent >1 ART proce-
dure in a given year is not possible. Because patients undergo-
ing >1 procedure in a given year are most likely to be those
who failed >1 treatment, the success rates reported here might
underestimate the true per-patient success rate. Second, these
data represent couples who sought ART services in 2000; there-
fore, success rates do not represent all couples with infertility
who were potential ART users in 2000. Third, 6% of medical
centers that performed ART in 2000 did not report their data
to CDC as required. Fourth, comparisons among states are
based on absolute numbers that are not adjusted for state popu-
lation size.
ART data are reported to CDC by the ART medical center
where the procedure was performed rather than by the state
where the patient resided. In this report, we present ART data
by the female patient’s state of residence. In previous reports
(16), we were unable to present ART data by state of resi-
dence because of incompleteness of residency data. In 2000,
residency data were missing for 10% of all live-birth deliver-
ies reported to CDC. The range of missing residency data
varied by medical center. Medical centers located in 35 states
had <5% missing residency data; medical centers located in
six states had 5%–9% missing residency data; medical centers
located in one state had 10%–15% missing residency data,
and medical centers located in six states had >15% missing
residency data. These states were Arizona, Georgia, Massa-
chusetts, Minnesota, New York, and Pennsylvania. In cases of
missing residency data, we assigned residency as the state in
which the ART procedure was performed. Thus, the number
of procedures performed among state residents, number of
infants, and number of multiple-birth infants might have been
overestimated for these states. Concurrently, the numbers
might be underestimated in states bordering states with miss-
ing data, particularly states in the Northeast region of the
United States. Nonetheless, the effects of missing residency
data were not substantial. We separately evaluated statistics
according to the state in which the ART medical center was
located rather than the patient’s state of residency. The rankings
of the states in terms of total number of infants and multiple-
birth infants were similar to the rankings based on state of
residency (data not shown).
Despite these limitations, findings from national surveil-
lance of ART procedures performed in the United States pro-
vide useful information for patients contemplating ART, ART¶ Estimated costs for one cycle of IVF range from $7,000 to $11,000 (8,9).
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TABLE 1. Outcomes of assisted reproductive technology (ART), by procedure type — United States, 2000
No. of No. of Live-birth
No. of ART procedures procedures Pregnancies No. of deliveries No. of
procedures progressing progressing No. of per transfer live-birth per transfer infants
ART procedure type started to retrievals to transfers pregnancies procedure (%) deliveries procedure (%) born
Patient’s eggs used
Freshly fertilized embryos 75,516 64,784 60,780 23,258 38.3 19,219 31.6 26,800
Thawed embryos 13,312 N/A* 11,602 2,975 25.6 2,360 20.3 3,048
Donor eggs used
Freshly fertilized embryos 7,919 7,243 6,989 3,566 51.0 3,041 43.5 4,382
Thawed embryos 2,882 N/A 2,544 758 29.8 608 23.9 795
Total 99,629 — 81,915 30,557 37.3 25,228 30.8 35,025
* Data not available.
providers, and health-care policy makers. First, ART surveil-
lance data can be used to monitor trends in ART use and
outcomes from ART procedures. Second, data from ART sur-
veillance can be used to assess patient and treatment factors
that contribute to higher success rates. Third, ongoing sur-
veillance data can be used to assess the risk of multiple births.
Fourth, surveillance data provide information to assess changes
in clinical practice related to ART treatment.
Multiple births are one of the most important public health
concerns associated with using ART. Increased use of ART
treatments and the widespread practice of transferring mul-
tiple embryos during ART treatments has led to a substantial
increase in multiple-birth rates in the United States (4,15).
Although balancing the chance of success with ART against
the risk of multiple births is difficult in certain cases, efforts
should be made to limit the number of embryos transferred
for patients undergoing ART. Such efforts will ultimately re-
quire ART patients and providers to view treatment success
in terms of singleton pregnancies and births. Additionally,
continued research is critical to understanding the effect of
ART on maternal and child health. CDC will continue to
provide updates of ART use in the United States as data be-
come available.
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TABLE 2. Number of reported assisted reproductive technology (ART) procedures performed, number of pregnancies, and number
of live-birth deliveries, by patient’s state/territory of residence* at time of treatment — United States, 2000
Patient’s state/ No. of ART No. of transfer No. of No. of live- No. of infants
territory of residence procedures started procedures pregnancies birth deliveries born
Alabama 578 476 174 144 216
Alaska 73 66 34 31 44
Arizona 1,111 907 359 299 444
Arkansas 371 293 116 105 142
California 13,194 11,352 4,009 3,245 4,453
Colorado 1,588 1,424 689 599 863
Connecticut 1,947 1,582 591 486 679
Delaware 438 290 107 86 117
District of Columbia 380 320 128 109 157
Florida 4,168 3,318 1,302 1,100 1,534
Georgia 2,308 1,794 677 570 774
Guam 1 1 0 0 0
Hawaii 457 358 105 93 128
Idaho 293 252 123 107 162
Illinois 7,323 5,820 1,883 1,551 2,137
Indiana 1,940 1,543 527 427 597
Iowa 800 613 243 202 275
Kansas 707 549 218 187 255
Kentucky 722 615 221 182 247
Louisiana 722 516 176 132 189
Maine 90 79 35 29 37
Maryland 3,202 2,581 994 825 1,153
Massachusetts 8,041 6,817 2,425 1,950 2,609
Michigan 3,420 2,765 938 801 1,122
Minnesota 1,943 1,705 789 669 908
Mississippi 268 217 71 61 84
Missouri 1,271 1,071 407 345 491
Montana 94 81 35 28 39
Nebraska 468 391 125 104 138
Nevada 735 633 251 211 313
New Hampshire 428 364 133 103 145
New Jersey 5,506 4,277 1,821 1,507 2,139
New Mexico 228 199 91 76 107
New York 11,239 9,238 3,432 2,753 3,771
North Carolina 1,551 1,300 510 429 638
North Dakota 174 131 50 40 51
Northern Mariana Islands 1 1 0 0 0
Ohio 2,349 1,921 698 593 843
Oklahoma 527 438 187 158 220
Oregon 748 571 241 219 321
Pennsylvania 3,511 2,770 917 742 997
Puerto Rico 344 301 113 81 112
Rhode Island 720 644 147 123 174
South Carolina 657 562 228 196 283
South Dakota 105 80 28 24 32
Tennessee 603 490 244 211 287
Texas 5,249 4,322 1,711 1,414 1,978
Utah 446 371 145 126 171
Vermont 127 111 39 31 40
Virgin Islands 8 8 1 1 1
Virginia 2,406 1,988 813 665 922
Washington 1,846 1,481 541 460 639
West Virginia 210 172 61 49 68
Wisconsin 879 765 265 224 305
Wyoming 46 41 20 17 26
Non U.S. resident 1,068 940 369 308 448
Total 99,629 81,915 30,557 25,228 35,025
* In cases of missing residency data, the patient’s state/territory of residence was assigned as the state in which the ART procedure was performed. Medical
centers in all but six states had missing residency data for <15% of infants born through ART. Medical centers located in Arizona, Georgia, Massachusetts,
Minnesota, New York, and Pennsylvania had >15% missing residency data.
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TABLE 3. Percentage distribution of selected patient and treatment factors for assisted reproductive technology (ART) transfer
procedures among patients who used freshly fertilized embryos from their own eggs, by patient age — United States, 2000
Patient age (yrs)
<35 35–37 38–40 41–42 >42
(n = 28,778) (n = 14,146) (n = 11,301) (n = 4,365) (n = 2,190)
(%) (%) (%) (%) (%)
Patient factors
Diagnosis
Tubal factor 16.8 18.3 16.3 12.9 9.2
Ovulatory dysfunction 7.0 4.5 3.6 3.4 2.8
Diminished ovarian reserve 1.2 1.9 5.0 12.0 22.1
Endometriosis 9.2 8.1 6.5 4.5 3.1
Uterine factor 0.8 1.4 1.5 2.1 1.8
Male factor 23.3 19.9 16.7 10.5 8.7
Other causes 4.6 5.3 6.6 9.1 10.6
Unexplained cause 9.7 11.4 11.9 11.2 10.8
Multiple factors, female only 10.5 11.6 13.6 16.3 13.5
Multiple factors, female and male 17.0 17.6 18.3 18.1 17.5
Number of previous ART procedures
0 59.8 50.0 45.9 43.8 39.8
>1 40.2 50.0 54.1 56.2 60.2
Number of previous births
0 81.0 71.8 68.0 64.9 64.5
>1 19.0 28.2 32.0 35.1 35.5
Treatment factors
Method of embryo fertilization and transfer*
IVF-ET without ICSI 42.5 44.9 45.9 49.2 48.5
IVF-ET with ICSI 55.7 53.3 52.1 49.0 47.8
GIFT 0.7 0.7 0.8 1.1 2.6
ZIFT 1.1 0.9 1.1 0.6 1.0
Combination 0.1 0.2 0.2 0.2 0.2
No. of days of embryo culture†
1 0.5 0.6 0.5 0.4 0.3
2 5.9 5.1 5.4 4.7 5.7
3 67.4 72.3 76.9 80.2 78.6
4 2.9 2.9 3.3 3.9 4.8
5 18.9 15.3 10.5 7.6 6.1
6 2.8 2.3 1.9 1.4 1.0
Number of embryos transferred
1 4.0 5.7 6.9 9.2 13.9
2 33.3 21.8 17.2 15.7 17.9
3 40.5 35.8 27.2 22.1 19.2
4 15.7 26.5 29.8 24.3 19.3
>5 6.5 10.1 18.8 28.7 29.7
Use of gestational carrier
Yes 0.7 0.8 1.0 0.9 1.0
No 99.3 99.3 99.0 99.1 99.0
* IVF-ET: in vitro fertilization with transcervical embryo transfer; ICSI: intracytoplasmic sperm injection; GIFT: gamete intrafallopian transfer; ZIFT: zygote
intrafallopian transfer; and Combination: combination of IVF with or without ICSI and either GIFT or ZIFT.
†
In cases of GIFT, gametes not cultured but transferred on day one.
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TABLE 4. Live-birth rates for assisted reproductive technology (ART) transfer procedures performed among patients who used
freshly fertilized embryos from their own eggs, by patient age and selected patient and treatment factors — United States, 2000
Patient age (yrs)
<35 35–37 38–40 41–42 >42
Live births Live births Live births Live births Live births
per transfer per transfer per transfer per transfer per transfer
procedure procedure procedure procedure procedure
 (%)  (%)  (%)  (%)  (%)
Total 38.4 33.0 24.3 14.3 6.0
Patient factors
Diagnosis
Tubal factor 37.6 33.0 25.1 13.3 5.4
Ovulatory dysfunction 40.2 35.8 25.6 17.7 6.6
Diminished ovarian reserve 31.2 29.6 19.5 13.9 4.8
Endometriosis 39.7 33.3 26.0 17.9 3.0
Uterine factor 34.8 33.2 20.8 22.2 15.0
Male factor 38.9 34.4 25.8 14.2 8.9
Other causes 37.8 30.6 25.2 16.1 6.5
Unexplained cause 41.4 36.9 27.5 15.1 5.1
Multiple factors, female only 37.4 32.0 23.2 12.4 6.8
Multiple factors, female and male 36.8 29.5 21.6 13.3 5.5
Number of previous ART procedures
0 40.6 35.0 25.8 14.8 6.0
>1 35.2 31.0 23.1 14.0 6.0
Number of previous births
0 37.3 31.7 23.1 13.4 6.0
>1 42.9 36.3 26.9 16.0 6.0
Treatment factors
Method of embryo fertilization and transfer*
IVF-ET without ICSI 40.7 35.5 26.2 15.5 7.0
IVF-ET with ICSI 36.7 31.0 22.5 13.0 4.9
Number of days of embryo culture†
3 37.7 32.8 24.4 14.4 5.8
5 44.4 37.7 29.6 18.2 7.5
Number of embryos transferred
1 14.7 11.2 8.0 2.7 2.0
2 42.1 31.6 19.0 10.1 2.6
3 39.7 36.1 25.4 11.5 7.4
4 35.4 34.1 28.4 16.3 6.4
>5 33.4 34.3 27.3 20.8 8.8
Use of gestational carrier
Yes 44.7 41.5 29.4 15.8 13.6
No 38.4 32.9 24.3 14.3 5.9
* IVF-ET: in vitro fertilization with transcervical embryo transfer, and ICSI: intracytoplasmic sperm injection.
†
Limited to 3 and 5 days to embryo culture. ART procedures including 1, 2, 4, and 6 days to embryo culture were not included because each of these
accounted for a limited proportion of procedures.
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TABLE 5. Multiple-birth risk, by type of assisted reproductive technology transfer procedure performed — United States, 2000
No. of Multiple- No. of infants Infants
Patient No. of multiple- birth No. of born in born in
age live-birth birth deliveries infants multiple-birth multiple-birth
 (yrs) deliveries deliveries  (%)* born deliveries deliveries (%)
Patient’s eggs used
Freshly fertilized embryos All ages 19,219 6,784 35.3 26,800 14,365 53.6
<35 11,050 4,263 38.6 15,866 9,079 57.2
35–37 4,663 1,648 35.3 6,489 3,474 53.5
38–40 2,750 747 27.2 3,558 1,555 43.7
41–42 625 110 17.6 739 224 30.3
>42 131 16 12.2 148 33 22.3
Thawed embryos All ages 2,360 609 25.8 3,048 1,297 42.6
<35 1,378 382 27.7 1,806 810 44.9
35–37 576 141 24.5 736 301 40.9
38–40 283 62 21.9 357 136 38.1
41–42 82 17 20.7 100 35 35.0
>42 41 7 17.1 49 15 30.6
Donor’s eggs used†
Freshly fertilized embryos All ages 3,041 1,236 40.6 4,382 2,577 58.8
Thawed embryos All ages 608 177 29.1 795 364 45.8
* Multiple-birth risk.
†
Age-specific statistics are not presented for procedures that used donor eggs because only limited variation occurred by age among these procedures.
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TABLE 6. Number and percentage of infants born in multiple-birth deliveries, by patient’s state/terrority of residence* at time of
assisted reproductive technology (ART) treatment — United States, 2000
Infants born
No. of No. of infants born Infants born in Infants born in triplet or
Patient’s state/ infants in multiple-birth multiple-birth  in twin higher order
territory of residence born deliveries deliveries (%)† deliveries (%) deliveries (%)
Alabama 216 128 59.3 35.2 24.1
Alaska 44 25 56.8 50.0 6.8
Arizona 444 264 59.5 43.2 16.2
Arkansas 142 70 49.3 40.8 8.5
California 4,453 2,315 52.0 45.2 6.8
Colorado 863 501 58.1 48.7 9.4
Connecticut 679 364 53.6 44.2 9.4
Delaware 117 59 50.4 42.7 7.7
District of Columbia 157 94 59.9 56.1 3.8
Florida 1,534 822 53.6 44.4 9.2
Georgia 774 385 49.7 39.7 10.1
Guam 0 0 0 0 0
Hawaii 128 69 53.9 46.9 7.0
Idaho 162 98 60.5 38.3 22.2
Illinois 2,137 1,099 51.4 40.2 11.2
Indiana 597 315 52.8 39.2 13.6
Iowa 275 141 51.3 44.7 6.5
Kansas 255 129 50.6 42.4 8.2
Kentucky 247 127 51.4 45.7 5.7
Louisiana 189 110 58.2 48.7 9.5
Maine 37 16 43.2 43.2 0
Maryland 1,153 630 54.6 46.3 8.3
Massachusetts 2,609 1,268 48.6 42.2 6.4
Michigan 1,122 603 53.7 42.6 11.1
Minnesota 908 449 49.4 39.3 10.1
Mississippi 84 41 48.8 31.0 17.9
Missouri 491 272 55.4 43.2 12.2
Montana 39 20 51.3 35.9 15.4
Nebraska 138 62 44.9 33.3 11.6
Nevada 313 195 62.3 53.7 8.6
New Hampshire 145 82 56.6 51.7 4.8
New Jersey 2,139 1,205 56.3 47.3 9.0
New Mexico 107 59 55.1 46.7 8.4
New York 3,771 1,946 51.6 44.0 7.6
North Carolina 638 390 61.1 48.6 12.5
North Dakota 51 22 43.1 43.1 0
Northern Mariana Islands 0 0 0 0 0
Ohio 843 464 55.0 42.2 12.8
Oklahoma 220 117 53.2 43.6 9.5
Oregon 321 193 60.1 49.8 10.3
Pennsylvania 997 483 48.4 40.5 7.9
Puerto Rico 112 56 50.0 33.9 16.1
Rhode Island 174 94 54.0 41.4 12.6
South Carolina 283 159 56.2 41.0 15.2
South Dakota 32 16 50.0 50.0 0
Tennessee 287 144 50.2 41.8 8.4
Texas 1,978 1,087 55.0 48.0 6.9
Utah 171 87 50.9 45.6 5.3
Vermont 40 18 45.0 45.0 0
Virgin Islands 1 0 0.0 0 0
Virginia 922 496 53.8 47.8 6.0
Washington 639 340 53.2 44.3 8.9
West Virginia 68 36 52.9 44.1 8.8
Wisconsin 305 157 51.5 45.2 6.2
Wyoming 26 18 69.2 69.2 0
Non U.S. resident 448 263 58.7 47.3 11.4
Total 35,025 18,603 53.1 44.2 8.9
* In cases of missing residency data, the patient’s state/territory of residence was assigned as the state in which the ART procedure was performed. Medical
centers in all but six states had missing residency data for <15% of infants born through ART. Medical centers located in Arizona, Georgia, Massachusetts,
Minnesota, New York, and Pennsylvania had >15% missing residency data.
†
Numbers might not sum to total because of rounding.
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Number of ART medical centers in the United States in 2000 408
Number of U.S. ART medical centers that submitted data in 2000 383
Number of ART cycles reported for 2000 99,629
Number of live-birth deliveries resulting from ART cycles started in 2000 25,228
Number of infants born as a result of ART cycles carried out in 2000 35,025
FIGURE 2. Live births per transfer and percentages of multiple-infant births for
assisted reproductive technology procedures performed among women aged <35
years who used freshly fertilized embryos from their own eggs, by number of
embryos transferred — United States, 2000







1 2 3 4 >5









































Triplets or higher order
Vol. 52 / SS-9 Surveillance Summaries 15
FIGURE 3. Live births per transfer and percentages of multiple-infant births for
assisted reproductive technology procedures performed among women aged 35–
37 years who used freshly fertilized embryos from their own eggs, by number of
embryos transferred — United States, 2000
* Numbers might not add to 100% because of rounding.
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FIGURE 4. Live births per transfer and percentages of multiple-infant births for
assisted reproductive technology procedures performed among women aged 38–
40 years who used freshly fertilized embryos from their own eggs, by number of
embryos transferred — United States, 2000
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FIGURE 5. Live births per transfer and percentages of multiple-infant births for
assisted reproductive technology procedures performed among women aged 41–
42 years who used freshly fertilized embryos from their own eggs, by number of
embryos transferred — United States, 2000
* Numbers might not add to 100% because of rounding.
†
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FIGURE 6. Live births per transfer and percentages of multiple-infant births for
assisted reproductive technology procedures performed among women aged >42
years who used freshly fertilized embryos from their own eggs, by number of
embryos transferred — United States, 2000
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1 : extending up to the immediate present,
including the very latest information;
see also MMWR.
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Morbidity and Mortality Weekly ReportCDC’s interim surveillance case definition for severe acute
respiratory syndrome (SARS) has been updated to include
laboratory criteria for evidence of infection with the SARS-
associated coronavirus (SARS-CoV) (Figure, Box). In addi-
tion, clinical criteria have been revised to reflect the possible
spectrum of respiratory illness associated with SARS-CoV. Epi-
demiologic criteria have been retained. The majority of U.S.
cases of SARS continue to be associated with travel*, with
only limited secondary spread to household members or
health-care providers (1).
SARS has been associated etiologically with a novel
coronavirus, SARS-CoV (2,3). Evidence of SARS-CoV
infection has been identified in patients with SARS in several
countries, including the United States. Several new labora-
tory tests can be used to detect SARS-CoV. Serologic testing
for coronavirus antibody can be performed by using indirect
fluorescent antibody or enzyme-linked immunosorbent
assays that are specific for antibody produced after infection.
Although some patients have detectable coronavirus antibody
during the acute phase (i.e., within 14 days of illness onset),
definitive interpretation of negative coronavirus antibody tests
is possible only for specimens obtained >21 days after onset
of symptoms. A reverse transcriptase polymerase chain reac-
tion (RT-PCR) test specific for viral RNA has been positive
within the first 10 days after onset of fever in specimens from
some SARS patients, but the duration of detectable viremia
or viral shedding is unknown. RT-PCR testing can detect
SARS-CoV in clinical specimens, including serum, stool, and
nasal secretions. Finally, viral culture and isolation have both
been used to detect SARS-CoV. Absence of SARS-CoV anti-
body in serum obtained <21 days after illness onset, a nega-
tive PCR test, or a negative viral culture does not exclude
coronavirus infection.
Reported U.S. cases of SARS still will be classified as sus-
pect or probable; however, these cases can be further classi-
fied as laboratory-confirmed or -negative if laboratory data
are available and complete, or as laboratory-indeterminate if
specimens are not available or testing is incomplete. Obtain-
ing convalescent serum samples to make a final determina-
tion about infection with SARS-CoV is critical.
No instances of SARS-CoV infection have been detected
in persons who are asymptomatic. However, data are insuffi-
cient to exclude the possibility of asymptomatic infection with
SARS-CoV and the possibility that such persons can trans-
mit the virus. Investigations of close contacts and health-care
workers exposed to SARS patients might provide informa-
tion about the occurrence of asymptomatic infected persons.
Similarly, the clinical manifestations of SARS might extend
Updated Interim Surveillance Case Definition for Severe Acute Respiratory Syndrome
(SARS) — United States, April 29, 2003
* In this updated case definition, Taiwan has been added to the areas with documented
or suspected community transmission of SARS; Hanoi, Vietnam is now an area
with recently documented or suspected community transmission of SARS.
FIGURE. Clinical and laboratory criteria for probable and
suspect severe acute respiratory syndrome (SARS) cases and
SARS-associated coronavirus (SARS-CoV) infection — United
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